Ragosa Mark
CHIEF FINANCIAL OFFICER at KNSA
- Sold, on record
- $12.5M
- Dollars the filings state
- Form 4 sales
- 16
- Latest Mar 9, 2026
- Form 144 notices
- 3
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- KNSAKiniksa Pharmaceuticals International, plcCHIEF FINANCIAL OFFICER
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale KNSARoutineJun 3 2025
Sold 18,299 shares at $28.80 ($527k)
Ragosa Mark, CHIEF FINANCIAL OFFICER
10b5-1 planSold 40.4% of holdings ($1.3M position)27,009 shares left0.8x usual sizeFiling
- 2 Form 4 sale KNSARoutineAug 4 +62 days
Sold 18,889 shares at $32.89 ($621k)
Ragosa Mark, CHIEF FINANCIAL OFFICER
10b5-1 planSold 41.2% of holdings ($1.5M position)27,009 shares left0.9x usual sizeFiling
- 3 Form 4 sale KNSARoutineOct 28 +85 days
Sold 100 shares at $41.00 ($4k)
Ragosa Mark, CHIEF FINANCIAL OFFICER
10b5-1 planSold 0.3% of holdings ($1.3M position)31,086 shares left0x usual sizeFiling
- 4 Form 4 sale KNSARoutineNov 12 +15 days
Sold 19,900 shares at $40.94 ($815k)
Ragosa Mark, CHIEF FINANCIAL OFFICER
10b5-1 planSold 39% of holdings ($2.1M position)31,086 shares left1.1x usual sizeFiling
- 5 Form 4 sale KNSARoutineDec 8 +26 days
Sold 42,841 shares at $41.49 ($1.8M)
Ragosa Mark, CHIEF FINANCIAL OFFICER
10b5-1 planSold 58% of holdings ($3.1M position)31,086 shares left2.2x usual sizeFiling
- 6 Form 4 sale KNSARoutineJan 8 +31 days
Sold 12,000 shares at $41.89 ($503k)
Ragosa Mark, CHIEF FINANCIAL OFFICER
10b5-1 planSold 38.6% of holdings ($1.3M position)19,086 shares left0.6x usual sizeFiling
- 7 Form 4 sale KNSARoutineFeb 9 +32 days
Sold 17,845 shares at $43.28 ($772k)
Ragosa Mark, CHIEF FINANCIAL OFFICER
10b5-1 planSold 59.6% of holdings ($1.3M position)12,086 shares left0.9x usual sizeFiling
- 8 Form 4 sale KNSARoutineMar 9 +28 days
Sold 36,722 shares at $45.92 ($1.7M)
Ragosa Mark, CHIEF FINANCIAL OFFICER
10b5-1 planSold 75.2% of holdings ($2.2M position)12,086 shares left1.9x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (19)
| Source | ||||||||
|---|---|---|---|---|---|---|---|---|
| Mar 9, 2026 | KNSA | CHIEF FINANCIAL OFFICER | Form 4 sale | 36,722 | $1.7M | 75.2% | Routine | SEC |
| Feb 9, 2026 | KNSA | CHIEF FINANCIAL OFFICER | Form 4 sale | 17,845 | $772k | 59.6% | Routine | SEC |
| Jan 8, 2026 | KNSA | CHIEF FINANCIAL OFFICER | Form 4 sale | 12,000 | $503k | 38.6% | Routine | SEC |
| Dec 8, 2025 | KNSA | CHIEF FINANCIAL OFFICER | Form 4 sale | 42,841 | $1.8M | 58.0% | Routine | SEC |
| Nov 12, 2025 | KNSA | CHIEF FINANCIAL OFFICER | Form 4 sale | 19,900 | $815k | 39.0% | Routine | SEC |
| Oct 28, 2025 | KNSA | CHIEF FINANCIAL OFFICER | Form 4 sale | 100 | $4k | 0.3% | Routine | SEC |
| Aug 4, 2025 | KNSA | CHIEF FINANCIAL OFFICER | Form 4 sale | 18,889 | $621k | 41.2% | Routine | SEC |
| Jun 3, 2025 | KNSA | CHIEF FINANCIAL OFFICER | Form 4 sale | 18,299 | $527k | 40.4% | Routine | SEC |
| May 1, 2025 | KNSA | CHIEF FINANCIAL OFFICER | Form 4 sale | 88,395 | $2.3M | 76.6% | Unusual | SEC |
| Mar 20, 2025 | KNSA | CHIEF FINANCIAL OFFICER | Form 4 sale | 15,944 | $368k | 40.5% | Routine | SEC |
| Mar 19, 2025 | KNSA | CHIEF FINANCIAL OFFICER | Form 4 sale | 20,343 | $470k | 46.5% | Routine | SEC |
| Mar 12, 2025 | KNSA | CHIEF FINANCIAL OFFICER | Form 4 sale | 36,372 | $809k | 61.3% | Routine | SEC |
| Dec 9, 2024 | KNSA | CHIEF FINANCIAL OFFICER | Form 4 sale | 27,829 | $594k | 54.8% | Routine | SEC |
| Dec 5, 2024 | KNSA | CHIEF FINANCIAL OFFICER | Form 4 sale | 15,116 | $323k | 39.7% | Routine | SEC |
| Dec 3, 2024 | KNSA | Officer | Form 144 notice | 72,754 | $1.5M | Notice | SEC | |
| Jul 23, 2024 | KNSA | CHIEF FINANCIAL OFFICER | Form 4 sale | 24,248 | $601k | 55.7% | Routine | SEC |
| Jul 23, 2024 | KNSA | Officer | Form 144 notice | 24,248 | $601k | Notice | SEC | |
| Jan 3, 2024 | KNSA | CHIEF FINANCIAL OFFICER | Form 4 sale | 12,000 | $240k | 43.4% | Routine | SEC |
| Jan 3, 2024 | KNSA | Officer | Form 144 notice | 12,000 | $240k | Notice | SEC |